DOI:
10.1055/s-00033101
Neurology International Open
LinksClose Window
References
Gómez-Gálvez Y, Palomo-Garo C, Fernández-Ruiz J. et al.
Potential of the cannabinoid CB2 receptor as a pharmacological target against inflammation in Parkinson’s disease.
Prog Neuro-Psychopharmacology Biol Psychiatry 2016;
64: 200-208
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.